DNDi is currently sourcing a contract research organization (CRO) to perform non GLP exploratory toxicology studies for 2 compounds targeting visceral leishmaniasis.
Archives: Requests for Proposals
DNDi is currently sourcing a Contract Research Organization (CRO) located in India to perform a MAD Phase 1 study for a product targeting visceral leishmaniasis.
The COVID Moonshot is a highly accelerated discovery project aiming to identify an orally available treatment for COVID-19. In order to perform all preclinical activities required to enable Phase I studies, DNDi is now sourcing a Contract Research Organization (CRO) offering an integrated platform capable of delivering the nonclinical safety and toxicology aspects of the project.